Moreover, recent evidence indicates that estrogen also contributes to the pathogenesis of BPH, with distinct roles for estrogen receptor subtypes ERα and ERβ in prostate cell growth, involving mechanisms like cell death, aromatase activity, and regulation via PGE2 [35]. The gene discussed is CYP19A1; the disease is benign prostatic hyperplasia.